SOURCE: OneMedPlace

OneMedPlace

November 17, 2009 14:48 ET

70 Companies Confirmed to Present at OneMedForum 2010 Investment Conference

OneMedPlace's Third Annual Finance Conference for Emerging Public and Private Healthcare Companies Will Be Held January 12-14 at San Francisco's Sir Francis Drake Hotel.

NEW YORK, NY--(Marketwire - November 17, 2009) - OneMedPlace reports that 70 healthcare and life science companies are confirmed to present at its "OneMedForum 2010" Finance Conference. The conference features tracks for both public and private firms as well as panel discussions.

Forum organizers also report that AdvaMed, the industry trade association, will be hosting the OneMedForum kick-off reception on January 12th. Kenny Mendez of AdvaMed has noted that the "OneMedForum 2010" Finance Conference is a captivating and unique event given the extraordinary pressure currently facing the medical technology industry. "Bringing together those responsible for building the companies of the future has never been more important. The Forum can help educate both investors and industry executives on critical issues they will face," he said.

Companies committed to present at the OneMedForum 2010 Finance Conference thus far include:

Access Pharmaceuticals (BB), Advanced Life Sciences (Nasdaq), ADVENTRX Pharmaceuticals (AMEX), Alexza Pharmaceuticals (Nasdaq), Aureon Laboratories (Private), BioDelivery Sciences International (Nasdaq), BioSante Pharmaceuticals (Nasdaq), Cardiogenesis Corporation (OTC), CardioPolymers (Private), Cardium Therapeutics (AMEX), Catheter Connections (Private), Clarient (Nasdaq), Conceptus (Nasdaq), Cyclacel Pharmaceuticals (Nasdaq), Cytori Therapeutics (Nasdaq), CytRx (Nasdaq), DARA BioSciences (Nasdaq), Data Physics Research (Private), DataTrak International (BB), Echo Therapeutics (Nasdaq), Elemé Medical (Private), Envisioneering Medical (Private), EpiCept (Nasdaq), ForteBio (Private), Hepregen (Private), HydraDx (Private), ImmunoCellular Therapeutics (BB), Impres Medical (Private), Inovio Biomedical (AMEX), IntelliDx (Private), Invendo Medical (Private), Ivivi Health Sciences (Private), Jaleva Pharmaceuticals (Private), Jennerex BioTherapeutics (Private), Kosin Technologies (Private), Lucid (Private), MedicaSafe (Private), Micrus Endovascular (Nasdaq), MiddleBrook Pharmaceuticals (Nasdaq), Minnow Medical (Private), MyoScience (Private), Nabi Biopharmaceuticals (Nasdaq), NovaBay Pharmaceuticals (AMEX), NovaDel Pharma (AMEX), NuVue Therapeutics (Private), Oculus Innovative Sciences (Nasdaq), OPKO Health (AMEX), OptiMedica (Private), Oxygen Biotherapeutics (BB), Patriot Data Solutions Group (BB), PaxVax (Private), Peregrine Pharmaceuticals (Nasdaq), Pico-Tesla Magnetic Therapies (Private), Pressure BioSciences, (Nasdaq), QuantRx Biomedical (OTCBB), Quantum Immunologics (Private), Quintessence Biosciences (Private), Safeguard Scientifics (NYSE), ScyFIX (Private), Senesco Technologies (AMEX), Spherix (Nasdaq), SRS Medical (Private), Strategic Medicine (Private), Telcare (Private), TRACON Pharmaceuticals (Private), Trubion Pharmaceuticals (Nasdaq), Viveve (Private), Vivostat A/S (Private), Woodside Logic (Private), and Xlumena (Private).

OneMedPlace also announces that it has teamed up with Lippert/Heilshorn & Associates (LHA) to arrange private one-on-one meetings for executives of companies presenting at OneMedForum 2010. LHA is a leading investor relations agency with a 25-year track record and a strong presence in the healthcare sector. In past years private rooms were available at the conference for participating companies to arrange their own meetings. But now for the first time OneMedForum is offering this service of targeting and active outreach to the investment professionals who matter most to presenting companies. Under this new program, companies can engage LHA to arrange one day or two days of meetings with members of the investment community. Meetings will take place with institutional investors, sell-side analysts and investment bankers, reflecting the preference of the presenting company.

To learn more about the event, or for information about applying to present at the OneMedForum event, visit www.onemedplace.com or contact Justin Schreiber at 212-734-1008 or via email jschreiber@onemedplace.com.

About OneMedPlace

OneMedPlace is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine -- emerging companies and technologies seeking capital, distribution, visibility, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.

Contact Information